Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.

NCT07192068 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Sarcoma
Head &Amp; Neck Cancer
Colorectal Carcinoma
Endometrial

Interventions

DRUG: Zanidatamab

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]